Comparative Analysis of Procalcitonin and C-Reactive Protein in Bloodstream Infections Among Febrile Neutropenic Pediatric Cancer Patients

Tanya Pandey; Rajkumar Kalyan; Tanya Sachan; Riya Singh; Sushmita Verma

doi:10.7759/cureus.101495

journal article Jan 13, 2026

Comparative Analysis of Procalcitonin and C-Reactive Protein in Bloodstream Infections Among Febrile Neutropenic Pediatric Cancer Patients

Tanya Pandey Rajkumar Kalyan Tanya Sachan Riya Singh Sushmita Verma

Cureus · Springer Science and Business Media LLC

View at Publisher Save 10.7759/cureus.101495

Topics

No keywords indexed for this article. Browse by subject →

References

20

[1]

Lucas AJ, Olin JL, Coleman MD. Management and preventive measures for febrile neutropenia. P T. 2018, 43:228-32.

[2]

Urbonas V, Eidukaitė A, Tamulienė I. Increased interleukin-10 levels correlate with bacteremia and sepsis in febrile neutropenia pediatric oncology patients. Cytokine. 2012, 57:313-15. 10.1016/j.cyto.2011.11.012 10.1016/j.cyto.2011.11.012

[3]

Arif T, Phillips RS. Updated systematic review and meta-analysis of the predictive value of serum biomarkers in the assessment and management of fever during neutropenia in children with cancer. Pediatr Blood Cancer. 2019, 66:e27887. 10.1002/pbc.27887 10.1002/pbc.27887

[4]

Mian A, Becton D, Saylors R, James L, Tang X, Bhutta A, Prodhan P. Biomarkers for risk stratification of febrile neutropenia among children with malignancy: a pilot study. Pediatr Blood Cancer. 2012, 59:238-45. 10.1002/pbc.24158 10.1002/pbc.24158

[5]

Aggarwal R, Bansal D, Bansal F, Nanda N, Ray P, Trehan A, Marwaha RK. Interleukin-5, interleukin-6, interleukin-8 and tumour necrosis factor-alpha levels obtained within 24-h of admission do not predict high-risk infection in children with febrile neutropenia. Indian J Med Microbiol. 2013, 31:226-29. 10.4103/0255-0857.115624 10.4103/0255-0857.115624

[6]

Samsudin I, Vasikaran SD. Clinical utility and measurement of procalcitonin. Clin Biochem Rev. 2017, 38:59-68.

[7]

Müller B, White JC, Nylen ES, Snider RH, Becker KL, Habener JF. Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab. 2001, 86:396-404. 10.1210/jc.86.1.396 10.1210/jc.86.1.396

[8]

Banerjee R. CON: Procalcitonin does not have clinical utility in children with community-acquired pneumonia. JAC Antimicrob Resist. 2021, 3:dlab152. 10.1093/jacamr/dlab152 10.1093/jacamr/dlab152

[9]

Fleischhack G, Kambeck I, Cipic D, Hasan C, Bode U. Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II. Br J Haematol. 2000, 111:1093-102. 10.1046/j.1365-2141.2000.02458.x 10.1046/j.1365-2141.2000.02458.x

[10]

Radhakrishnan V, Vijaykumar V, Ganesan P, Rajendranath R, Trivadi G, Tenali S. Bloodstream infections in pediatric patients at Cancer Institute, Chennai. Indian J Cancer. 2014, 51:418-19. 10.4103/0019-509X.175360 10.4103/0019-509x.175360

[11]

Freifeld AG, Bow EJ, Sepkowitz KA, et al.. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2011, 52:e56-93. 10.1093/cid/cir073 10.1093/cid/cir073

[12]

Beqja-Lika A, Bulo-Kasneci A, Refatllari E, Heta-Alliu N, Rucaj-Barbullushi A, Mone I, Mitre A. Serum procalcitonine levels as an early diagnostic indicator of sepsis. Mater Sociomed. 2013, 25:23-5. 10.5455/msm.2013.25.23-25 10.5455/msm.2013.25.23-25

[13]

Shilpakar R, Paudel BD, Neupane P, et al.. Procalcitonin and C-reactive protein as markers of bacteremia in patients with febrile neutropenia who receive chemotherapy for acute leukemia: a prospective study from Nepal. J Glob Oncol. 2019, 5:1-6. 10.1200/JGO.19.00147 10.1200/jgo.19.00147

[14]

Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med. 2003, 31:1737-41. 10.1097/01.CCM.0000063440.19188.ED 10.1097/01.ccm.0000063440.19188.ed

[15]

Massaro KS, Costa SF, Leone C, Chamone DA. Procalcitonin (PCT) and C-reactive protein (CRP) as severe systemic infection markers in febrile neutropenic adults. BMC Infect Dis. 2007, 7:137. 10.1186/1471-2334-7-137 10.1186/1471-2334-7-137

[16]

Meisner M, Tschaikowsky K, Palmaers T, Schmidt J. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care. 1999, 3:45-50. 10.1186/cc306 10.1186/cc306

[17]

Secmeer G, Devrim I, Kara A, et al.. Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia. J Pediatr Hematol Oncol. 2007, 29:107-11. 10.1097/MPH.0b013e3180320b5b 10.1097/mph.0b013e3180320b5b

[18]

Doganci M, Eraslan Doganay G, Sazak H, et al.. The utility of c-reactive protein, procalcitonin, and leukocyte values in predicting the prognosis of patients with pneumosepsis and septic shock. Medicina (Kaunas). 2024, 60:10.3390/medicina60101560 10.3390/medicina60101560

[19]

Liu X, Lian J, Liu F, Han D, Sang C. Clinical application of combined CRP and PCT detection in diagnosing and prognosing fracture-related infections. Front Cell Infect Microbiol. 2025, 15:1563170. 10.3389/fcimb.2025.1563170 10.3389/fcimb.2025.1563170

[20]

Cho J, Lee JH, Lee DH, Kim J, Uh Y. Performance comparison of procalcitonin, delta neutrophil index, c-reactive protein, and serum amyloid a levels in patients with hematologic diseases. Diagnostics (Basel). 2023, 13:10.3390/diagnostics13071213 10.3390/diagnostics13071213

Metrics

0

Citations

20

References

Details

Published: Jan 13, 2026

Authors

Cite This Article

Tanya Pandey, Rajkumar Kalyan, Tanya Sachan, et al. (2026). Comparative Analysis of Procalcitonin and C-Reactive Protein in Bloodstream Infections Among Febrile Neutropenic Pediatric Cancer Patients. Cureus. https://doi.org/10.7759/cureus.101495

Comparative Analysis of Procalcitonin and C-Reactive Protein in Bloodstream Infections Among Febrile Neutropenic Pediatric Cancer Patients

You May Also Like